Wiltshire4:1
|
|
|
BEZ235
|
Bcells_BEZ
52401
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:7
|
|
|
BEZ235
|
Tcells_BEZ
52407
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:13
|
|
|
BEZ235
|
monocytes_BEZ
52413
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:21
|
|
|
doxorubicin
|
Bcells_Dox
52421
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:27
|
|
|
doxorubicin
|
Tcells_Dox
52427
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:33
|
|
|
doxorubicin
|
monocytes_Dox
52433
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:41
|
|
|
idarubicin
|
Bcells_Ida
52441
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:47
|
|
|
idarubicin
|
Tcells_Ida
52447
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:53
|
|
|
idarubicin
|
monocytes_Ida
52453
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:61
|
|
|
selumetinib
|
Bcells_Sel
52461
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:67
|
|
|
selumetinib
|
Tcells_Sel
52467
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:73
|
|
|
selumetinib
|
monocytes_Sel
52473
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|